L. Belmont

874 total citations
19 papers, 154 citations indexed

About

L. Belmont is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Epidemiology. According to data from OpenAlex, L. Belmont has authored 19 papers receiving a total of 154 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pulmonary and Respiratory Medicine, 8 papers in Oncology and 5 papers in Epidemiology. Recurrent topics in L. Belmont's work include Lung Cancer Research Studies (6 papers), Lung Cancer Treatments and Mutations (6 papers) and Lung Cancer Diagnosis and Treatment (3 papers). L. Belmont is often cited by papers focused on Lung Cancer Research Studies (6 papers), Lung Cancer Treatments and Mutations (6 papers) and Lung Cancer Diagnosis and Treatment (3 papers). L. Belmont collaborates with scholars based in France, United States and New Caledonia. L. Belmont's co-authors include Marie Wislez, Jacques Cadranel, A. Lavolé, Martine Antoine, Nathalie Rabbe, V. Gounant, Anne-Marie Ruppert, B. Milleron, Jin Su and Robert A. Sclafani and has published in prestigious journals such as Journal of Clinical Oncology, Genetics and International Journal of Cancer.

In The Last Decade

L. Belmont

16 papers receiving 153 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
L. Belmont France 7 77 73 37 33 24 19 154
Silvia Chiellino Italy 7 102 1.3× 61 0.8× 61 1.6× 16 0.5× 23 1.0× 17 205
Shen Lao China 6 89 1.2× 39 0.5× 50 1.4× 52 1.6× 19 0.8× 11 172
Qingyi Wang China 8 62 0.8× 20 0.3× 32 0.9× 35 1.1× 15 0.6× 24 168
Enxiao Li China 6 106 1.4× 55 0.8× 36 1.0× 9 0.3× 13 0.5× 11 160
László Landherr Hungary 8 122 1.6× 62 0.8× 42 1.1× 11 0.3× 61 2.5× 20 191
Kathia Cristina Abdalla Brazil 6 50 0.6× 40 0.5× 35 0.9× 19 0.6× 15 0.6× 13 147
Shirley Mo United States 6 82 1.1× 45 0.6× 35 0.9× 45 1.4× 34 1.4× 11 178
Ryotaro Ohkuma Japan 9 126 1.6× 50 0.7× 27 0.7× 51 1.5× 14 0.6× 15 174
M. Marcq France 9 87 1.1× 148 2.0× 22 0.6× 13 0.4× 26 1.1× 28 197
Yuya Hirasawa Japan 8 115 1.5× 71 1.0× 21 0.6× 48 1.5× 17 0.7× 18 172

Countries citing papers authored by L. Belmont

Since Specialization
Citations

This map shows the geographic impact of L. Belmont's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Belmont with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Belmont more than expected).

Fields of papers citing papers by L. Belmont

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. Belmont. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Belmont. The network helps show where L. Belmont may publish in the future.

Co-authorship network of co-authors of L. Belmont

This figure shows the co-authorship network connecting the top 25 collaborators of L. Belmont. A scholar is included among the top collaborators of L. Belmont based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. Belmont. L. Belmont is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Guisier, Florian, Pernelle Lavaud, Laurent Greillier, et al.. (2024). Lurbinectedin in extensive-stage small-cell lung cancer: a brief report of the IFCT-2105 LURBICLIN study. ESMO Open. 9(12). 103968–103968. 2 indexed citations
2.
Leblanc, Serge, Michaël Génin, Florent Occelli, et al.. (2024). Association épidémiologique entre pollution et altérations oncogéniques dans le cancer du poumon. Revue des Maladies Respiratoires Actualités. 16(1). 19–20.
3.
Falchero, L., Olivier Molinier, Faraj Al Freijat, et al.. (2024). Real-life nationwide characteristics and outcomes of small cell lung cancer over the last 20 years: Impact of immunotherapy on overall survival in a real-life setting. European Journal of Cancer. 210. 114277–114277. 2 indexed citations
4.
Chang, Junn-Liang, Peter E. Haroldsen, Andrew M. Standeven, et al.. (2024). 115 (PB103): Investigation of cabozantinib and zanzalintinib differentiation via in vitro kinase profiling and in vivo tissue and tumor distribution. European Journal of Cancer. 211. 114638–114638.
5.
6.
Belmont, L., et al.. (2019). Intégrer les enjeux d’adaptation au changement climatique dans l’action des Parcs naturels régionaux. Sciences Eaux & Territoires. Numéro 28(2). 16–16.
7.
8.
Lavolé, A., C. Toper, L. Belmont, et al.. (2013). Cancer du poumon et infection par le Virus de l’Immunodéficience Humaine. Revue des Maladies Respiratoires. 31(2). 133–141. 7 indexed citations
9.
Belmont, L., Nathalie Rabbe, Martine Antoine, et al.. (2013). Expression of TLR9 in tumor‐infiltrating mononuclear cells enhances angiogenesis and is associated with a worse survival in lung cancer. International Journal of Cancer. 134(4). 765–777. 37 indexed citations
10.
Fallet, Vincent, Anne-Marie Ruppert, Virginie Poulot, et al.. (2012). Secondary Resistance to Erlotinib: Acquired T790M Mutation and Small-Cell Lung Cancer Transformation in the Same Patient. Journal of Thoracic Oncology. 7(6). 1061–1063. 16 indexed citations
11.
Antoine, Martine, M. Duruisseaux, Virginie Poulot, et al.. (2012). Clinical and molecular features in patients with advanced non-small-cell lung carcinoma refractory to first-line platinum-based chemotherapy. Lung Cancer. 79(2). 167–172. 33 indexed citations
12.
Lavolé, A., Laurence Baudrin, V. Gounant, et al.. (2012). Routine administration of a single dose of cisplatin ≥ 75 mg/m2 after short hydration in an outpatient lung-cancer clinic. Bulletin du Cancer. 99(4). E43–E48. 21 indexed citations
13.
Vieira, Thibault, Aurélie Cazes, P. Bonnette, et al.. (2012). Is conventional chemotherapy effective in advanced sarcomatoid lung cancers?. Journal of Clinical Oncology. 30(15_suppl). e18102–e18102. 4 indexed citations
14.
Meyer, Guy & L. Belmont. (2011). Maladie veineuse thromboembolique et cancer. Revue des Maladies Respiratoires. 28(4). 443–452. 1 indexed citations
15.
Ruppert, Anne-Marie, Michèle Beau‐Faller, L. Belmont, et al.. (2011). Un regard simple sur la biologie du cancer bronchique : MET. Revue des Maladies Respiratoires. 28(10). 1241–1249. 7 indexed citations
16.
Planquette, Benjamin, L. Belmont, Guy Meyer, & Olivier Sanchez. (2011). Prise en charge diagnostique et thérapeutique de l’embolie pulmonaire grave. Revue des Maladies Respiratoires. 28(6). 778–789. 3 indexed citations
17.
Antoine, Martine, Virginie Poulot, L. Belmont, et al.. (2011). Caractéristiques associées à la résistance à un doublet à base de platine dans les cancers bronchiques non à petites cellules (CBNPC) de stades IIIb-IV. Revue des Maladies Respiratoires. 29. A46–A47. 2 indexed citations
18.
Wislez, Marie, Raphaël Borie, L. Belmont, et al.. (2009). Lymphomes pulmonaires primitifs. 20(2). 1–10. 1 indexed citations
19.
Su, Jin, L. Belmont, & Robert A. Sclafani. (1990). Genetic and molecular analysis of the SOE1 gene: a tRNA(3Glu) missense suppressor of yeast cdc8 mutations.. Genetics. 124(3). 523–531. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Silvia Chiellino Breakdown of academic impact, for papers by Shen Lao Breakdown of academic impact, for papers by Qingyi Wang Breakdown of academic impact, for papers by Enxiao Li Breakdown of academic impact, for papers by László Landherr Breakdown of academic impact, for papers by Kathia Cristina Abdalla Breakdown of academic impact, for papers by Shirley Mo Breakdown of academic impact, for papers by Ryotaro Ohkuma Breakdown of academic impact, for papers by M. Marcq Breakdown of academic impact, for papers by Yuya Hirasawa
Rankless by CCL
2026